Home Authors Posts by Tess Egginton

Tess Egginton

Tess Egginton
1448 POSTS 0 COMMENTS
http://www.pbiforum.net

CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus...

US FDA approves BOOSTRIX for immunisation during pregnancy for the prevention...

£8.8 million to speed up gene discoveries for lung conditions

Lilly receives U.S. FDA Fast Track designation for tirzepatide for the...

Surrozen partners with Boehringer Ingelheim to develop treatment for retinal diseases

Intravacc awarded $14.6m NIH/NIAID contract to develop intranasal gonorrhoea vaccine

Pfizer completes $5.4bn acquisition of Global Blood Therapeutics

Ziphius Vaccines and UZ Ghent establish collaboration for GMP manufacturing of...

Incyte to acquire Villaris Therapeutics

agreement

Alexion, AstraZeneca Rare Disease to acquire LogicBio Therapeutics to accelerate growth...

1...108109110...145Page 109 of 145

News

AstraZeneca enters license agreement with Alteogen for subcutaneous formulations of oncology assets

AstraZeneca and Alteogen have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme platform technology. Under the terms of the agreement,...

AstraZeneca to acquire EsoBiotec in $1bn deal

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical...
Canada

SKYCLARYS approved by Health Canada for Friedreich’s ataxia

Health Canada has approved Biogen's SKYCLARYS (omaveloxolone) for the treatment of Friedreich’s ataxia (FA) in patients 16 years of age and older. This approval...

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks